Telerehabilitation in Cancer Patients: Optimization of Prehabilitation and Rehabilitation Following Colorectal Resection
CCR
1 other identifier
interventional
54
1 country
1
Brief Summary
This study, titled: Telerehabilitation in Oncology Patients: Optimization of Prehabilitation and Rehabilitation Post-Colorectal Resection. Is a randomized clinical trial conducted at the Royo Villanova Hospital in Zaragoza, Spain. It aims to evaluate the effectiveness of a tele-rehabilitation program in enhancing functional capacity and quality of life for patients undergoing colorectal cancer surgery. Colorectal cancer (CRC) is a highly prevalent malignant tumor that significantly impacts global health and patients\' quality of life, particularly after surgery. Prehabilitation and postoperative rehabilitation are crucial for recovery, and telerehabilitation offers a promising alternative to improve outcomes in CRC patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable colorectal-cancer
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2024
CompletedStudy Start
First participant enrolled
August 30, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedSeptember 19, 2025
September 1, 2025
1.6 years
August 29, 2024
September 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Capacity - Six Minute Walking Test (6MWT)
The primary outcome is the improvement in functional capacity, which will be evaluated using the Six Minute Walking Test (6MWT). This test measures the maximum distance a patient can walk in six minutes along a flat, straight corridor under controlled conditions. The results provide an objective assessment of the patient\'s functional capacity, reflecting their ability to perform daily activities and their level of postoperative recovery.
Functional capacity will be assessed at four time points: pre-intervention (T1), the day before surgery (T2), 21 days post-surgery (T3), and 50 days post-surgery (T4).
Secondary Outcomes (13)
Pulmonary Capacity - Spirometry Assessments
Measured at pre-intervention (T1), the day before surgery (T2), 21 days post-surgery (T3), and 50 days post-surgery (T4).
Upper Limb Muscle Strength - Hand Grip Test
Measured at pre-intervention (T1), the day before surgery (T2), 21 days post-surgery (T3), and 50 days post-surgery (T4).
Lower Limb Muscle Strength - Sit to Stand Test
Measured at pre-intervention (T1), the day before surgery (T2), 21 days post-surgery (T3), and 50 days post-surgery (T4).
Body Composition - Bioelectrical Impedance Analysis and Waist-to-Hip Ratio
Measured at pre-intervention (T1), the day before surgery (T2), 21 days post-surgery (T3), and 50 days post-surgery (T4).
Postoperative Complications - Comprehensive Complication Index (CCI)
Evaluated 3 months post-surgery (T5).
- +8 more secondary outcomes
Study Arms (2)
Intervention Group. Asynchronous telerehabilitation
EXPERIMENTALReceive a home-based rehabilitation program via an asynchronous digital telerehabilitation platform.
Control Group. Booklet-based rehabilitation
ACTIVE COMPARATORReceive a booklet-based rehabilitation program at home through a detailed printed guide (explanatory booklet).
Interventions
Participants in the intervention group will receive a home-based rehabilitation program delivered via an asynchronous digital telerehabilitation platform. The multimodal program is accessible at online platform and it is composed for therapeutic exercises, including aerobic and strength training exercises, aimed at improving functional capacity and quality of life before and after colorectal cancer surgery.
Participants in the control group will receive a booklet-based rehabilitation program at home, provided through a detailed printed guide (explanatory booklet). This guide includes instructions in pictures and text for the multimodal program. It is composed for therapeutic exercises, including aerobic and strength training exercises, aimed at improving functional capacity and quality of life before and after colorectal cancer surgery.
Eligibility Criteria
You may qualify if:
- Age between 18 and 80 years.
- Participants who understand Spanish.
- Patients scheduled for colorectal cancer surgery at Royo Villanova Hospital, Zaragoza, Spain.
- Patients attending the first consultation in the General and Digestive Surgery Section under the supervision of Dr. Blas, head of surgery at Royo Villanova Hospital, Zaragoza, Spain.
- Participants with functional independence that allows them to perform walking and pulmonary function tests.
- Patients with a preoperative assessment score of I, II, or III on the American Society of Anesthesiologists (ASA) scale.
- Participants who agree to participate and sign the informed consent form.
You may not qualify if:
- Patients older than 80 years.
- Patients with a preoperative ASA score of IV.
- Patients with any injury, pathology, or inflammatory processes that make it impossible to practice exercise.
- Patients with central and/or peripheral neurological diseases that prevent them from following the rehabilitation program.
- Patients with unstable cardiac comorbidities such as arrhythmias, high blood pressure, angina pectoris, or other conditions that contraindicate moderate-intensity training.
- Patients diagnosed with a psychiatric disorder as confirmed by a psychiatrist.
- Patients without access to mobile internet or a computer with internet at home.
- Patients who score ≤ 24 on the Mini-Mental State Examination (MMSE).
- Individuals who are unable to follow oral and written instructions in Spanish.
- Patients who refuse to participate in the study or who have not signed the informed consent form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Instituto de Investigación Sanitaria Aragónlead
- Universidad de Zaragozacollaborator
- Universidad San Jorgecollaborator
- Hospital Royo Villanova de Zaragozacollaborator
Study Sites (1)
Hospital Royo Villanova
Zaragoza, Zaragoza, 50015, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra Calvo, PhD
Universidad de Zaragoza
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single Blind (Outcomes Assessor)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
August 29, 2024
First Posted
September 19, 2024
Study Start
August 30, 2024
Primary Completion
April 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
September 19, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share